TuHURA Biosciences, Inc. HURA Income Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $0— | $0— | $0— | ||
| $20.53M+54.0% | $13.34M+41.8% | $9.4M— | ||
| —— | $3.87M-6.5% | $4.14M— | ||
| $31.8M+80.2% | $17.65M-40.7% | $29.76M— | ||
| —— | $4.14M+22,044% | $18.69K— | ||
| $1.74M-25.4% | $2.34M+1,491% | $147K— | ||
| -$30.05M-38.6% | -$21.68M+26.0% | -$29.32M-29.4% | ||
| -$0.63— | —— | -$2.47— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is TuHURA Biosciences, Inc. profitable?
- TuHURA Biosciences, Inc. is not currently profitable: it reported a net loss of $30.9M over the trailing twelve months.
- What is TuHURA Biosciences, Inc.'s earnings per share?
- TuHURA Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-0.61.
- Where does TuHURA Biosciences, Inc.'s income statement data come from?
- Every line is extracted from TuHURA Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.